Artal Group S.A. Seer, Inc. Transaction History

Artal Group S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$27.67 - $45.04 $23.2 Million - $37.8 Million	-838,366 Reduced 15.0%	4,750,000 $164 Million
Q1 2021 May 14, 2021	SELL	$38.67 - $84.06 $9.77 Million - $21.2 Million	-252,545 Reduced 4.32%	5,588,366 $280 Million
Q4 2020 Feb 11, 2021	BUY	$55.23 - $81.11 $323 Million - $474 Million	5,840,911 New	5,840,911 $328 Million

35.2M

600

Ticker SEER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,566,500
Market Cap $135M
Description
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.